Cargando…
Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters
Background and objectives: The use of non-invasive techniques to predict the histological type of renal masses can avoid a renal mass biopsy, thus being of great clinical interest. The aim of our study was to assess if quantitative multiphasic multidetector computed tomography (MDCT) enhancement pat...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692100/ https://www.ncbi.nlm.nih.gov/pubmed/33126571 http://dx.doi.org/10.3390/medicina56110569 |
_version_ | 1783614432946946048 |
---|---|
author | Moldovanu, Claudia-Gabriela Petresc, Bianca Lebovici, Andrei Tamas-Szora, Attila Suciu, Mihai Crisan, Nicolae Medan, Paul Buruian, Mircea Marian |
author_facet | Moldovanu, Claudia-Gabriela Petresc, Bianca Lebovici, Andrei Tamas-Szora, Attila Suciu, Mihai Crisan, Nicolae Medan, Paul Buruian, Mircea Marian |
author_sort | Moldovanu, Claudia-Gabriela |
collection | PubMed |
description | Background and objectives: The use of non-invasive techniques to predict the histological type of renal masses can avoid a renal mass biopsy, thus being of great clinical interest. The aim of our study was to assess if quantitative multiphasic multidetector computed tomography (MDCT) enhancement patterns of renal masses (malignant and benign) may be useful to enable lesion differentiation by their enhancement characteristics. Materials and Methods: A total of 154 renal tumors were retrospectively analyzed with a four-phase MDCT protocol. We studied attenuation values using the values within the most avidly enhancing portion of the tumor (2D analysis) and within the whole tumor volume (3D analysis). A region of interest (ROI) was also placed in the adjacent uninvolved renal cortex to calculate the relative tumor enhancement ratio. Results: Significant differences were noted in enhancement and de-enhancement (diminution of attenuation measurements between the postcontrast phases) values by histology. The highest areas under the receiver operating characteristic curves (AUCs) of 0.976 (95% CI: 0.924–0.995) and 0.827 (95% CI: 0.752–0.887), respectively, were demonstrated between clear cell renal cell carcinoma (ccRCC) and papillary RCC (pRCC)/oncocytoma. The 3D analysis allowed the differentiation of ccRCC from chromophobe RCC (chrRCC) with a AUC of 0.643 (95% CI: 0.555–0.724). Wash-out values proved useful only for discrimination between ccRCC and oncocytoma (43.34 vs 64.10, p < 0.001). However, the relative tumor enhancement ratio (corticomedullary (CM) and nephrographic phases) proved useful for discrimination between ccRCC, pRCC, and chrRCC, with the values from the CM phase having higher AUCs of 0.973 (95% CI: 0.929–0.993) and 0.799 (95% CI: 0.721–0.864), respectively. Conclusions: Our observations point out that imaging features may contribute to providing prognostic information helpful in the management strategy of renal masses. |
format | Online Article Text |
id | pubmed-7692100 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76921002020-11-28 Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters Moldovanu, Claudia-Gabriela Petresc, Bianca Lebovici, Andrei Tamas-Szora, Attila Suciu, Mihai Crisan, Nicolae Medan, Paul Buruian, Mircea Marian Medicina (Kaunas) Article Background and objectives: The use of non-invasive techniques to predict the histological type of renal masses can avoid a renal mass biopsy, thus being of great clinical interest. The aim of our study was to assess if quantitative multiphasic multidetector computed tomography (MDCT) enhancement patterns of renal masses (malignant and benign) may be useful to enable lesion differentiation by their enhancement characteristics. Materials and Methods: A total of 154 renal tumors were retrospectively analyzed with a four-phase MDCT protocol. We studied attenuation values using the values within the most avidly enhancing portion of the tumor (2D analysis) and within the whole tumor volume (3D analysis). A region of interest (ROI) was also placed in the adjacent uninvolved renal cortex to calculate the relative tumor enhancement ratio. Results: Significant differences were noted in enhancement and de-enhancement (diminution of attenuation measurements between the postcontrast phases) values by histology. The highest areas under the receiver operating characteristic curves (AUCs) of 0.976 (95% CI: 0.924–0.995) and 0.827 (95% CI: 0.752–0.887), respectively, were demonstrated between clear cell renal cell carcinoma (ccRCC) and papillary RCC (pRCC)/oncocytoma. The 3D analysis allowed the differentiation of ccRCC from chromophobe RCC (chrRCC) with a AUC of 0.643 (95% CI: 0.555–0.724). Wash-out values proved useful only for discrimination between ccRCC and oncocytoma (43.34 vs 64.10, p < 0.001). However, the relative tumor enhancement ratio (corticomedullary (CM) and nephrographic phases) proved useful for discrimination between ccRCC, pRCC, and chrRCC, with the values from the CM phase having higher AUCs of 0.973 (95% CI: 0.929–0.993) and 0.799 (95% CI: 0.721–0.864), respectively. Conclusions: Our observations point out that imaging features may contribute to providing prognostic information helpful in the management strategy of renal masses. MDPI 2020-10-28 /pmc/articles/PMC7692100/ /pubmed/33126571 http://dx.doi.org/10.3390/medicina56110569 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Moldovanu, Claudia-Gabriela Petresc, Bianca Lebovici, Andrei Tamas-Szora, Attila Suciu, Mihai Crisan, Nicolae Medan, Paul Buruian, Mircea Marian Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters |
title | Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters |
title_full | Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters |
title_fullStr | Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters |
title_full_unstemmed | Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters |
title_short | Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters |
title_sort | differentiation of clear cell renal cell carcinoma from other renal cell carcinoma subtypes and benign oncocytoma using quantitative mdct enhancement parameters |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692100/ https://www.ncbi.nlm.nih.gov/pubmed/33126571 http://dx.doi.org/10.3390/medicina56110569 |
work_keys_str_mv | AT moldovanuclaudiagabriela differentiationofclearcellrenalcellcarcinomafromotherrenalcellcarcinomasubtypesandbenignoncocytomausingquantitativemdctenhancementparameters AT petrescbianca differentiationofclearcellrenalcellcarcinomafromotherrenalcellcarcinomasubtypesandbenignoncocytomausingquantitativemdctenhancementparameters AT leboviciandrei differentiationofclearcellrenalcellcarcinomafromotherrenalcellcarcinomasubtypesandbenignoncocytomausingquantitativemdctenhancementparameters AT tamasszoraattila differentiationofclearcellrenalcellcarcinomafromotherrenalcellcarcinomasubtypesandbenignoncocytomausingquantitativemdctenhancementparameters AT suciumihai differentiationofclearcellrenalcellcarcinomafromotherrenalcellcarcinomasubtypesandbenignoncocytomausingquantitativemdctenhancementparameters AT crisannicolae differentiationofclearcellrenalcellcarcinomafromotherrenalcellcarcinomasubtypesandbenignoncocytomausingquantitativemdctenhancementparameters AT medanpaul differentiationofclearcellrenalcellcarcinomafromotherrenalcellcarcinomasubtypesandbenignoncocytomausingquantitativemdctenhancementparameters AT buruianmirceamarian differentiationofclearcellrenalcellcarcinomafromotherrenalcellcarcinomasubtypesandbenignoncocytomausingquantitativemdctenhancementparameters |